The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Seal of approval scheme needed for complementary and alternative websites

ty and to identify the most popular forms of CAM currently discussed.

"Two websites stood out for their excellent quality, both scoring 14 Quackwatch and Bandolier." said Ms Schmidt. "Two listed the HON code of approval[2] the US National Cancer Institute Cancer Facts, and Quackwatch."

The survey also scored the sites for whether their information could harm patients. Three of the 32 fell into the two high-risk categories by overtly discouraging patients from using conventional cancer care.

Ms Schmidt said: "Overall, 16% provided information that discouraged patients from using conventional treatment, 3% discouraged patients from adhering to clinicians' advice, 91% provided opinions, experiences and factual details and 22% provided mainly commercial details."

Of the total CAM therapies advertised, 118 were for cure, 88 for palliative/supportive care and 59 for prevention. The researchers carried out extensive literature searches in scientific and medical databases to assess the evidence of the top five CAM modalities suggested for preventative, curative and palliative care.

They concluded of the recommended therapies that:

  • Coenzyme Q10, one of the most frequently discussed, did not seem to warrant a positive recommendation as the evidence to date was far from compelling;
  • There was insufficient evidence for shark cartilage frequently recommended as a cancer 'cure' with the only published clinical study failing to produce encouraging results;
  • Clinical trials for laetrile, which contains the toxic compound amygdalin, had found no relevant benefit for cancer patients;
  • The Gerson diet was not supported by convincing evidence one study reporting a six-fold increase in 5-year survival for melanoma compared to rates reported in the medical literature was too methodologically flawed to allow any firm conclusions;
  • A review of all 10 randomised controlled trials for mistlet
    '"/>


Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-1536-772181
European Society for Medical Oncology
14-Apr-2004


Page: 1 2 3

Related medicine news :

1. New substance that improves the photodetection of bladder cancer gains market approval
2. NYUS Duster cautions against FDA approval of race-based pharmaceutical
3. Pioneering nanosystems degree wins approval
4. US FDA grants full approval to DOXIL(R) following submission of phase III data
5. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
6. Pfizers antifungal medicine VFEND receives FDA approval
7. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder
8. FDA grants accelerated approval of TYSABRI, formerly antegren, for the treatment of MS
9. Serono receives FDA approval for Gonal-f RFF Pen to treat infertility
10. First global approval for FOSRENOL (lanthanum carbonate)
11. Breakthrough cancer treatment Avastin receives first approval in the US

Post Your Comments:
(Date:11/24/2009)...ov.24/PRNewswire/--Mostpeoplelookforwardtokickingo...getherwithfriendsandfamily.TheMacombCountyHealthDe...gtheholidays.Travelingandbeinginlargegroupsareeasy...ayhealthy: ,, VACCINATION ,, Thefirstandmo...togetvaccinatedagainsttheH1N1strainoftheflu.TheMac...
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarew...pingHispanic-AmericanseniorsunderstandthebasicsofM...takeafreeZumba®Goldclass,aLatin-infusedfitnes...a,rumba,andtango. ,, UnitedHealthcarewilloffert...andengagedwhenlearningabouttheirhealthcareoptions....
(Date:11/24/2009)...Newswire-FirstCall/--CenteneCorporation(NYSE: CNC ...dhasselectedCenteneasoneoftwoCoordinatedCareOrgani...essNetwork(MississippiCAN),acoordinatedcareprogram...ngwiththeDivisiontoexecuteacontractinwhichthecompa...noliaHealthPlan(Magnolia). ,, BasedinJackson,Mi...
(Date:11/24/2009)...the falls that plague older adults, study finds, ... Falls are a leading cause of death among older Am...in contributes to those accidents. , "Pain cont... and is associated with mobility limitations that .... , "Chronic pain, no matter how we measured it...
(Date:11/24/2009)...ewswire-USNewswire/--TheAmericanDentalAssociation(...nnewdentalteammembersaspartofapilotprogramtoimprov...ommunityDentalHealthCoordinator(CDHC)isamemberofth...tshavelimitedaccesstodentalcaretoimprovetheiroralh...ivedentalcareservices--includingscreeningsandfluor...
Breaking Medicine News(10 mins):Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
(Date:11/24/2009)...ov.24/PRNewswire/--ZargisMedicalCorp.,asubsidiaryo...sCorporateResearch(NYSE: SI ),todayannouncedthatit...2009episodeofCBS, TheEarlyShow duringasegmentinwhi...eviewedfivewinningproductsfromthepublication,s2009...dely-viewedtelevisionmorningnewstalkshowbroadcastb...
(Date:11/24/2009)...PRNewswire/--AmbitBiosciencesCorporationannouncedt...AC220,anovelsecondgenerationFLT3inhibitor,inAMLatt...)tobeheldinNewOrleans,LA,December5-8,2009.Anoralpr...lPhaseImonotherapysafetystudyinadultswithacutemyel...bepresentedevaluatingtheeffectofAC220monotherapyan...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--EchoTherapeutics,Inc....e-freeSymphony(TM)tCGMSystemasanon-invasive,wirele...temanditsPrelude(TM)SkinPrepSystemfortransdermaldr...ChairmanandChiefExecutiveOfficer,willpresentatthe1...nce,sponsoredbytheNewYorkSocietyofSecuritiesAnalys...
Breaking Medicine Technology:Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 1YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 4Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35
Other News:
... research shows that the plant estrogens in soy do...igned to test a theory that high-soy diets can com...m Wake Forest University Baptist Medical Center an...ed today at the annual meeting of the American Soc...
... little improvement in the first 24 hours after re... more likely to have poor outcomes or death at thr...JAMA. Several factors, including elevated blood gl... of lack of improvement. ......According to backgr...
...asing the use of screening mammography among targe...to achieve the largest reduction in late-stage bre...dy in the October 20 issue of the Journal of the N...n editorial in the same issue suggests that certai...
...d other food products that contain high-fructose c... fresh makeover using honey, one of the most ancie... the University of Illinois at Urbana-Champaign sa...orn syrup due to its higher level of antioxidants,...
health news:Soy likely doesn't affect fertility, according to research in monkeys 2health news:Lack of improvement 24 hours after stroke treatment associated with poor outcome at 3 months 2health news:Study examines reasons for late-stage breast cancers 2
...ck Hispanics in America are suffering higher rates...who are white, a new study finds.......Researcher ...ogy with Columbia University's school of public he...pertension along racial lines within the Hispanic ...
...earch to Prevent Blindness (RPB), a New York-based...th organization supporting eye research, awarded 8........."RPB remains committed to fueling the vision...lped to build in departments of ophthalmology acro...
...surgical cancer therapy that destroys tumors but l...vailable at every hospital if research reported th...fruition.......The Los Alamos National Laboratory ...ers from the University of Nevada, Reno and elsewh...
...unising newborn infants of mothers with hepatitis ... to child, finds a study published online by the B...tis B carriers worldwide. The virus is transmitted...ed person. Mother to child transmission around the...
health news:Hypertension data may mask racial disparities among Hispanics 2health news:Grants from research to prevent blindness surpass $7.9 million in 2005 2